Treatment
Publisher
Springer London
Reference12 articles.
1. Kuo C-C, Grayston JT. In vitro drug susceptibility of Chlamydia strain TWAR. Antimicrobial Agents Chemother 1988;32(2):257–258.
2. Strigl S, Roblin PM, Reznik T. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob Agents Chemother 2000;44(4):1112–1113.
3. Stewart CE, Coleman K, Mortenson J. Effect of extended pre-incubation with Chlamydia pneumoniae and extended incubation with antimicrobials on the minimum inhibitory concentration (MIC) of five antimicrobials. Diagn Microbiol Infect Dis 2001;40:207–209.
4. Cuffini C, Alberto Guzman L, Villegas N, et al. Isolation of Chlamydia pneumoniae from atheromas of the carotid artery and their antibiotics susceptibility profile. Enferm Infecc Microbiol Clin 2006;24(2):81–85.
5. Gieffers J, Solbach W, Maass M. In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic arteries. Antimicrob Agents Chemother 1998;42(10):2762–2764.